Bacteria Strains

Bacteria Strains Vetom

Bacteria properties.

• antiviral effect;

• inhibits the growth and development of intracellular infectious agents of a viral nature (chlamydia, ricketsia, bacteria, protozoa);

• antiproliferative activity;

• antitumorogenic effect;

• antimutagenic effect;

• antitoxic action;

• radioprotective effect;

• stimulates macrophages and enhances phagocytosis;

• enhances the cytotoxic action of sensitized lymphocytes on target cells;

• enhances the formation of surface antigens;

• enhances or suppresses the activity of several cellular enzymes;

• enhances the cytotoxic effect domiteeva RNA;

• suppresses or enhances the production of antibodies;

• activates natural killer cells;

• stimulates the release of histamine by basophils;

• enhances the synthesis of prostaglandins;

• enhances the formation of histocompatibility antigens;

• suppresses the hypersensitivity of the delayed type.

Bacteria Bacillus subtilis and Bacillus licheniformis are not members of the normal flora in the microbial communities of humans and animals, but have properties that provide the body:

 

• opportunity to support microbianos at the level of ecologically natural;

• optimize metabolism and supply the body with biologically active substances and construction;

• provide quality digestion of food.

Bacteria application.

• the first-inflammatory processes of the skin and soft tissue (cellulites, folliculitis, boils, carbuncles, hydradenitis, pharyngitis, tonsillitis, rhinitis, panaritiums, abscesses, cellulitis, pyoderma, etc.);

• systemic staph infection (acute and chronic purulent otitis, conjunctivitis, sinusitis, mediastinitis, pericarditis, mastitis, appendicitis, cholecystitis, pancreatitis, anal fistula and anorectal abscess, peritonitis, enteritis, colitis, pyelonephritis, pielity, urethritis, cystitis, salpingoophoritis, osteomyelitis, meningitis, ampacity, panaritiums, etc.);

• esherihioz (cystitis, pyelitis, cholecystitis, ending sometimes colibacillinum sepsis);

• intestinal infections (diseases, diarrhoea);

• lesions of the urinary tract;

• salmonellosis (typhoid and paratyphoid, gastroenteritis and septicaemia);

• skin lesions, abscesses, infection of burn lesions, keratitis, otitis, external ear (including malignant);

• foodborne illness (often clinical disease due to the development of gastritis, enteritis, colitis, or combination thereof);

• oropharyngeal candidiasis (cheilitis, gingivitis, zaedy, glossitis, stomatitis, pharyngitis);

• candidiasis of the esophagus (complications: bleeding, stricture), inflammation of the stomach and intestinal candidiasis, etc.;

• pneumonia;

• hospital respiratory (bronchitis and pneumonia);

• lesions of the urinary tract, meninges, joints, eyes;

• chronic fetid atrophic rhinitis;

• infectious gastroenteritis, acute intestinal infections (aII), infections of the genitourinary system (IPS);

• diarrhea, urinary and septic diseases of children and adults;

• yersiniosis is an infectious disease, accompanied by diarrhea, enteritis, pseudoappendicitis, ileitis, knotty eritremia and (sometimes) septicemia or acute arthritis;

• bacterial dysenteria or shigellosis;

• kidney infections and urinary tract infections (acute pyelonephritis exacerbation of chronic prostatitis).

Bacteria - Interferon.

The route of administration of interferon and stimulate the developments of endogenous interferons, based on the introduction into the body of the above microorganisms, ensures a prolonged the life span of the colony of microorganisms in the digestive tract (or other organs) effects on the body of interferons and, as a consequence, to achieve a positive effect in the treatment and prevention of a wide range of different diseases.

The range of diseases where it is shown interferon can be divided into three large groups:


Infectious diseases:

 

• various forms of herpetic lesions (viral keratoconjunctivitis and keratitis, keratouveitis, genital herpes, shingles);

• acute and chronic viral hepatitis (A, B, C, D (Delta));

• SARS (reno, coronavirus infection, influenza viruses and parainfluenza);

• AIDS;

• human papillomavirus infection (genital warts, juvenile laryngeal papillomatosis, warts, etc.);

• encephalitis (tick-borne);

• serous meningitis various etiology;

• measles;

• mumps;

• rabies;

• cytomegalovirus infection;

• viral complications in organ transplantation application of immunosuppressive drugs;

• subacute sclerosing panencephalitis;

• purulent-septic diseases of newborns;

• postnatal acquired chronic cytomegalovirus infection;

• psoriasis;

• multiple sclerosis;

• various bacterial diseases (chlamydia, legionelles, literally, ricketsiosis).

Cancer:

 

• B-cell and T-cell malignancies of the blood (leukemia);

• lymphoma (b-cell chronic lymphocytic leukemia, multiple myeloma;

• thrombocytopenia (essential thrombocythemia and secondary thrombocytosis, etc.);

• solid tumors (carcinomas (keratoacanthoma), glioma, malignant melanoma; hematopoietic neoplasia; hairy cell leukemia; chronic myelogenous leukemia);

• malignant T-cell lymphomas (mycosis fungoides, primary retikulez; vaginal cancer);

• basal cell and squamous cell carcinoma of the skin;

• Kaposi's sarcoma alone and in association with HIV infection;

• warts are common, genital, and flat juvenile;

• tumors of the head, neck, and brain;

• ovarian cancer;

• cervical cancer;

• breast cancer;

• bladder cancer;

• lung cancer;

• papillomatosis of the larynx;

• cancer of the kidney.

• children infection;

• infectious toxicosis;

• excess body weight;

• reduction of leukocytosis and neutrophilia;

• diabetes mellitus;

• arthrosis and arthritis.

Bacteria dosage.

Currently on the market there are drugs in various formulations: powders, capsules, suppositories, liquids, gels. Depending on the type of disease, its localization, severity of disease, etc. the person needs to choose the right physical form, frequency and duration of use.

When selecting dosage and frequency reception, you must keep in mind that the therapeutic effect depends not on the quantity of the drug accepted a lump sum, and the multiplicity of application – the more, the higher the therapeutic effect.